![Mardi Dier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mardi Dier
Director of Finance/CFO at
MADRIGAL PHARMACEUTICALS, INC.
Net worth: 39 200 $ as of 2026-05-30
Profile
Ms. Mardi C. Dier is a Chief Financial Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., an Independent Director at Oric Pharmaceuticals, Inc. and an Independent Director at Adamas Pharmaceuticals, Inc. She is on the Board of Directors at Prelude Therapeutics, Inc., Oric Pharmaceuticals, Inc. and Adamas Pharmaceuticals, Inc. Ms. Dier was previously employed as a CFO, Chief Business Officer & Executive VP by Portola Pharmaceuticals, Inc., a Vice President-Investor Relations by Chiron Corp., a Director-Investment Banking by Prudential Equity Group LLC, a Senior Accountant by KPMG LLP, a Senior Accountant by KPMG Peat Marwick LLP, and a Director-Investment Banking by Prudential Securities. She also served on the board at Jewish Vocational Service, Inc. and Futures Strategic Trust. She received her undergraduate degree from Stanford University and an MBA from UCLA Anderson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-06-11 | 10,000 ( 0.02% ) | 39 200 $ | 2026-05-30 | |
| 2026-03-31 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Mardi Dier active positions
| Companies | Position | Start |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Director/Board Member | 2020-01-31 |
| MADRIGAL PHARMACEUTICALS, INC. | Director of Finance/CFO | 2024-03-10 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Consultant / Advisor | - |
Synthekine, Inc.
 Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Director/Board Member | 2021-06-02 |
Former positions of Mardi Dier
| Companies | Position | End |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Director/Board Member | 2025-10-16 |
| ACELYRIN, INC. | Director of Finance/CFO | 2023-08-01 |
| ULTRAGENYX PHARMACEUTICAL INC. | Director of Finance/CFO | 2022-11-14 |
| ADAMAS PHARMACEUTICALS, INC. | Director/Board Member | 2021-06-08 |
| PORTOLA PHARMACEUTICALS, INC. | Director of Finance/CFO | 2020-06-30 |
Training of Mardi Dier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Futures Strategic Trust
 Futures Strategic Trust Investment Banks/BrokersFinance Invests in commodities contracts | Finance |
Prudential Securities
 Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG Peat Marwick LLP
 KPMG Peat Marwick LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Prudential Equity Group LLC
 Prudential Equity Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
Jewish Vocational Service, Inc.
 Jewish Vocational Service, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization that provides adult education and workforce development services | Commercial Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Synthekine, Inc.
Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
- Stock Market
- Insiders
- Mardi Dier
